HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NME2 Is a Master Suppressor of Apoptosis in Gastric Cancer Cells via Transcriptional Regulation of miR-100 and Other Survival Factors.

Abstract
Tumorigenesis is a result of uncontrollable cell proliferation which is regulated by a variety of complex factors including miRNAs. The initiation and progression of cancer are always accompanied by the dysregulation of miRNAs. However, the underlying mechanism of miRNA dysregulation in cancers is still largely unknown. Herein we found that miR-100 was inordinately upregulated in the sera of patients with gastric cancer, indicating that miR-100 might emerge as a biomarker for the clinical diagnosis of cancer. The abnormal expression of miR-100 in gastric cancer cells was mediated by a novel transcription factor NME2 (NME/NM23 nucleoside diphosphate kinase 2). Further data revealed that the transcription factor NME2 could promote the transcriptions of antiapoptotic genes including miRNA (i.e., miR-100) and protein-encoding genes (RIPK1, STARD5, and LIMS1) through interacting with RNA polymerase II and RNA polymerase II-associated protein 2 to mediate the phosphorylation of RNA polymerase II C-terminal domain at the 5th serine, leading to the suppression of apoptosis of gastric cancer cells both in vitro and in vivo. In this context, our study revealed that the transcription factor NME2 is a master suppressor for apoptosis of gastric cancer cells. IMPLICATIONS: Our study contributed novel insights into the mechanism involved in the expression regulation of apoptosis-associated genes and provided a potential biomarker of gastric cancer.
AuthorsYi Gong, Geng Yang, Qizhi Wang, Yumeng Wang, Xiaobo Zhang
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 18 Issue 2 Pg. 287-299 (02 2020) ISSN: 1557-3125 [Electronic] United States
PMID31694930 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2019 American Association for Cancer Research.
Chemical References
  • MIRN100 microRNA, human
  • MicroRNAs
  • NM23 Nucleoside Diphosphate Kinases
  • NME2 protein, human
Topics
  • Animals
  • Apoptosis (physiology)
  • Carcinogenesis (pathology)
  • Cell Line, Tumor
  • Cell Proliferation (physiology)
  • Genes, Tumor Suppressor
  • Heterografts
  • Humans
  • Mice
  • Mice, Nude
  • MicroRNAs (genetics, metabolism)
  • NM23 Nucleoside Diphosphate Kinases (genetics, metabolism)
  • Stomach Neoplasms (genetics, metabolism, pathology)
  • Survival Analysis
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: